The store will not work correctly when cookies are disabled.
N-(2-(5-(phenoxymethyl)isoxazol-3-yloxy)ethyl)cyclobutanamine
ID: ALA4743313
PubChem CID: 162645680
Max Phase: Preclinical
Molecular Formula: C16H20N2O3
Molecular Weight: 288.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(OCc2cc(OCCNC3CCC3)no2)cc1
Standard InChI: InChI=1S/C16H20N2O3/c1-2-7-14(8-3-1)20-12-15-11-16(18-21-15)19-10-9-17-13-5-4-6-13/h1-3,7-8,11,13,17H,4-6,9-10,12H2
Standard InChI Key: BGNLRKAAEJHUCK-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
14.1418 -7.9335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9668 -7.9335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2236 -7.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5543 -6.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8892 -7.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1045 -6.8947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4917 -7.4471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7069 -7.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5403 -6.3841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7563 -6.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1425 -6.6819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3179 -7.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1016 -7.7434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0086 -6.8954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6209 -7.4484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4060 -7.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0183 -7.7474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8032 -7.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5345 -7.8712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9101 -7.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1755 -6.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
3 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.35 | Molecular Weight (Monoisotopic): 288.1474 | AlogP: 2.77 | #Rotatable Bonds: 8 |
Polar Surface Area: 56.52 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.38 | CX LogP: 2.81 | CX LogD: 0.85 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.76 | Np Likeness Score: -1.26 |
References
1. Ye N,Qin W,Tian S,Xu Q,Wold EA,Zhou J,Zhen XC. (2020) Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases., 63 (24.0): [PMID:33111525] [10.1021/acs.jmedchem.0c01192] |